The "Glymphatic" Window on Neurodegeneration in Synucleinopathies

被引：1
|
作者：
Filippi, Massimo [1 ,2 ,3 ,4 ,5 ]
Balestrino, Roberta [2 ,3 ,5 ]
机构：
[1] IRCCS San Raffaele Sci Inst, Inst Expt Neurol, Div Neurosci, Neuroimaging Res Unit, Via Olgettina 60, I-20132 Milan, Italy
[2] IRCCS San Raffaele Sci Inst, Neurol Unit, Via Olgettina 60, I-20132 Milan, Italy
[3] IRCCS San Raffaele Sci Inst, Neurorehabil Unit, Via Olgettina 60, I-20132 Milan, Italy
[4] IRCCS San Raffaele Sci Inst, Neurophysiol Serv, Via Olgettina 60, I-20132 Milan, Italy
[5] Univ Vita Salute San Raffaele, Milan, Italy
来源：
RADIOLOGY | 2023年 / 307卷 / 05期
关键词：
FUNCTIONAL MRI;
D O I：
10.1148/radiol.230817
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [31] GLAUCOMA: AN OPEN-WINDOW TO NEURODEGENERATION AND NEUROPROTECTION Preface
    Nucci, Carlo
    Bagetta, Giacinto
    Osborne, Neville N.
    Cerulli, Luciano
    GLAUCOMA: AN OPEN WINDOW TO NEURODEGENERATION AND NEUROPROTECTION, 2008, 173 : XI - XI
  • [32] The optic nerve: A "mito-window" on mitochondrial neurodegeneration
    Maresca, Alessandra
    la Morgia, Chiara
    Caporali, Leonardo
    Valentino, Maria Lucia
    Carelli, Valerio
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2013, 55 : 62 - 76
  • [33] RNAi for the Treatment of Prion Disease: A Window for Intervention in Neurodegeneration?
    White, Melanie D.
    Mallucci, Giovanna R.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2009, 8 (05) : 342 - 352
  • [34] Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease
    Huang, Shu-Yi
    Zhang, Ya-Ru
    Guo, Yu
    Du, Jing
    Ren, Peng
    Wu, Bang-Sheng
    Feng, Jian-Feng
    Cheng, Wei
    Yu, Jin-Tai
    ALZHEIMERS & DEMENTIA, 2024, 20 (05) : 3251 - 3269
  • [35] REM sleep behaviour disorder: an early window for prevention in neurodegeneration?
    Weil, Rimona S.
    Morris, Huw R.
    BRAIN, 2019, 142 : 498 - 501
  • [36] Naproxen reduces excitotoxic neurodegeneration in vivo with an extended therapeutic window
    Silakova, JM
    Hewett, JA
    Hewett, SJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (03): : 1060 - 1066
  • [37] Imaging in Parkinson disease - a window to neurodegeneration, a tool to assess neuroprotection?
    Marek, K
    ARCHIVES OF NEUROLOGY, 2000, 57 (08) : 1237 - 1237
  • [38] Vitreous haze as a novel marker for neurodegeneration in MS possibly indicating impairment of the retinal glymphatic system.
    Coric, D.
    Ometto, G.
    Montesanto, G.
    Denniston, A.
    Keane, P.
    Balk, L.
    Uitdehaag, B.
    Crabb, D.
    Petzold, A.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 44 - 45
  • [39] The α-synucleinopathies
    Spillantini, MG
    Goedert, M
    BRAIN PATHOLOGY, 2000, 10 (04) : 494 - 494
  • [40] Glymphatic dysfunction and neurodegeneration in ALS: Longitudinal insights from rNLS8 TDP-43 mice
    Zamani, Akram
    Walker, Adam K.
    Wright, David K.
    NEUROBIOLOGY OF DISEASE, 2025, 206
12345